NVP VAD 463

Drug Profile

NVP VAD 463

Alternative Names: NVPVAD-463

Latest Information Update: 19 Jul 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Novartis
  • Class Antiallergics; Benzodiazepines
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic asthma; Allergic contact dermatitis; Allergic rhinitis

Most Recent Events

  • 19 Jul 2010 Discontinued - Preclinical for Allergic asthma in Austria (unspecified route)
  • 19 Jul 2010 Discontinued - Preclinical for Allergic contact dermatitis in Austria (unspecified route)
  • 19 Jul 2010 Discontinued - Preclinical for Allergic rhinitis in Austria (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top